A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...

Fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are debilitating conditions, and patients can ...

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...

Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a ...

FROM MGM+ Season 4 Episode 9 aired June 21, and its supernatural mechanics — bottle trees, shapeshifting, storywalking, Fatima’s transformation — each map to a named scientific framework: Kongo ...

Legend Biotech Corporation (NASDAQ:LEGN) is one of the most promising healthcare stocks according to Wall Street analysts.

People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a ...

The treatment, currently designated HTX-001, is an antisense oligonucleotide, or ASO, that targets Wisper and reduces the ...

Swamp Thing 1989 #3 hits stores Wednesday! Will our mossy hero choose cosmic unity or marital bliss? The ultimate existential crisis awaits!

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. Care and Feeding is Slate’s parenting ...

( NewsNation) — Scientists have treated the first person in a clinical trial testing whether aging cells can be “reprogrammed ...

New biotech is helping scientists pull back the curtain on the developing brain and reveal the causes of the condition ...